Fortitude Family Office, LLC

Family Office

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1950506 SCOTTSDALE, AZ

Position in VRTX

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$35,764

+$2,274 QoQ

Shares Held

-4.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#1,550

of 1,732 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Fortitude Family Office, LLC holds $736,227 across 148 Biotechnology names. VRTX ranks #4 (4.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	523	$157,438
2	INCY	Incyte Corp	641	$72,663
3	RVMD	Revolution Medicines, Inc.	292	$54,685
4	VRTX	Vertex Pharmaceuticals Inc / Ma This page	72	$35,764
5	JAZZ	Jazz Pharmaceuticals plc	128	$30,844
6	FTRE	Fortrea Holdings Inc.	1,647	$28,657
7	RLAY	Relay Therapeutics, Inc.	1,268	$23,724
8	ARWR	Arrowhead Pharmaceuticals, Inc.	228	$18,584

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$35,764	72	-4.0%	Shares	Sole	2026-07-20
2026-03-31	$33,490	75	+47.1%	Shares	Sole	2026-04-16
2025-12-31	$23,121	51	0.0%	Shares	Sole	2026-01-15
2025-09-30	$19,973	51	-5.6%	Shares	Sole	2025-10-17
2025-06-30	$24,040	54	-29.9%	Shares	Sole	2025-07-15
2025-03-31	$37,331	77	0.0%	Shares	Sole	2025-04-16
2024-12-31	$31,007	77	+5.5%	Shares	Sole	2025-01-10
2024-09-30	$33,950	73	0.0%	Shares	Sole	2024-10-25
2024-06-30	$34,216	73	0.0%	Shares	Sole	2024-07-10
2024-03-31	$30,514	73	0.0%	Shares	Sole	2024-04-11
2023-12-31	$29,702	73	—	Shares	Sole	2024-01-12
No filing history on record for this holder in this stock.